1st longer term tirzepatide study (3 years)
Docs Who Lift
00:00
Intro
This chapter delves into the speakers' reflections on the Obesity Week conference, emphasizing groundbreaking research on tirzepatide. They specifically discuss the importance of long-term data from surmount trials and the ongoing debates about the roles of resistance versus aerobic training in relation to new obesity treatments.
Transcript
Play full episode
